Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sustained-release nutritional vc lutein peptide chewable tablet and preparation method thereof

A slow-release nutrition and yellow protein technology, applied in the fields of peptide/protein ingredients, dairy products, milk preparations, etc., can solve the problems of lack of core competitiveness, lack of vision protection, low quality of personnel, etc., to achieve diverse ingredients and improve taste , the effect of natural materials

Active Publication Date: 2022-08-09
SHANGHAI JIAO TONG UNIV +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The social emphasis on eye care and eye care has also attracted a lot of social capital to enter this industry, but eye care companies generally lack core competitiveness, have single products and services, and low-quality personnel.
Some medicines exaggerate the curative effect and replace medical measures with health care measures, which has brought great negative effects to the industry
Moreover, there is a lack of active peptides that can effectively protect eyesight, slow release and release active peptides that are beneficial to vision protection, nourish eye nerves, improve immunity, provide nutrition for brain cells, and improve intelligence. chewable tablets

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sustained-release nutritional vc lutein peptide chewable tablet and preparation method thereof
  • Sustained-release nutritional vc lutein peptide chewable tablet and preparation method thereof
  • Sustained-release nutritional vc lutein peptide chewable tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] A slow-release nutritional VC lutein peptide chewable tablet provided in this embodiment, each 1g of the chewable tablet includes the following components:

[0050] Colostrum powder 6mg, goat milk powder 100mg, whey protein concentrate 10mg, marine fish oligopeptide 8mg, casein phosphopeptide 5mg, soybean peptide 6mg, soybean protein powder 5mg, sea cucumber peptide 100mg, oyster peptide 13mg, fruit and vegetable powder 10mg, Lactose 4mg, Resistant Dextrin 1mg, Chitooligosaccharide 1mg, Fructooligosaccharide 10mg, Vitamin C 80mg, Lutein Esters 5mg, Xylo-oligosaccharide 1mg, Erythritol 0.5mg, Sorbitol 15mg, Citric Acid 0.05mg , silicon dioxide 0.05mg, maltodextrin 10mg, magnesium stearate 0.5mg; targeted slow-release biocompatible microcapsules 20mg.

[0051] Among them, the targeted sustained-release biocompatible microcapsules, in terms of weight components, include the following components: 15 parts of polycarbonate films with a pore size of 180 nm and a thickness of ...

Embodiment 2

[0077] A slow-release nutritional VC lutein peptide chewable tablet provided in this embodiment, each 1g of the chewable tablet includes the following components:

[0078] Colostrum powder 50mg, goat milk powder 10mg, whey protein concentrate 150mg, marine fish oligopeptide 1mg, casein phosphopeptide 70mg, soybean peptide 0.5mg, soybean protein powder 0.5mg, sea cucumber peptide 13mg, oyster peptide 100mg, fruit and vegetable powder 100mg, lactose 1mg, resistant dextrin 5mg, chitosan oligosaccharide 10mg, fructooligosaccharide 1mg, vitamin C 5mg, lutein ester 100mg, xylo-oligosaccharide 0.6mg, erythritol 10mg, sorbitol 0.5mg, Citric acid 1mg, silicon dioxide 1mg, maltodextrin 0.08mg, magnesium stearate 1mg; targeted slow-release biocompatible microcapsules 30mg;

[0079] Targeted sustained-release biocompatible microcapsules, in terms of components by weight, include the following components: 20 parts of polycarbonate films with a pore size of 250 nm and a thickness of 15 mm; ...

Embodiment 3

[0105] A slow-release nutritional VC lutein peptide chewable tablet provided in this embodiment, each 1g of the chewable tablet includes the following components:

[0106] Colostrum powder 28mg, goat milk powder 55mg, whey protein concentrate 80mg, marine fish oligopeptide 4.5mg, casein phosphopeptide 37.5mg, soybean peptide 3.25mg, soybean protein powder 5.25mg, sea cucumber peptide 56.5mg, oyster peptide 56.5 mg, fruit and vegetable powder 55mg, lactose 2.5mg, resistant dextrin 3mg, chitooligosaccharide 5.5mg, fructooligosaccharide 5.5mg, vitamin C 42.5mg, lutein ester 52.5mg, xylo-oligosaccharide 0.8mg, erythrose Alcohol 5.25mg, sorbitol 7.5mg, citric acid 0.5mg, silicon dioxide 0.5mg, maltodextrin 5mg, magnesium stearate 0.75mg; targeted slow-release biocompatible microcapsules 25mg;

[0107] Targeted sustained-release biocompatible microcapsules, in terms of components by weight, include the following components: 18 parts of polycarbonate films with a pore size of 200 nm ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Thicknessaaaaaaaaaa
Apertureaaaaaaaaaa
Login to View More

Abstract

The invention provides a slow-release nutritional VC lutein peptide chewable tablet and a preparation method thereof. The chewable tablet includes the following components: bovine colostrum powder, goat milk powder, whey protein concentrate, marine fish oligopeptide, casein Protein phosphopeptide, soybean peptide, soybean protein powder, sea cucumber peptide, oyster peptide, fruit and vegetable powder, lactose, resistant dextrin, chitosan oligosaccharide, fructooligosaccharide, vitamin C, lutein ester, xylo-oligosaccharide, erythromycin Sugar alcohol, sorbitol, citric acid, silicon dioxide, maltodextrin, magnesium stearate; also includes targeted sustained-release biocompatible microcapsules. The chewable tablet prepared by the preparation method and composition provided by the present invention can release marine fish oligopeptide, casein phosphopeptide, sea cucumber peptide, soybean peptide and oyster peptide with nutritional effect in the intestinal tract, and can pass through the blood-brain barrier and act on Eye cells, repair eye fatigue and provide lutein ester and citric acid needed for eye work, provide brain cells to work and improve brain nutrition.

Description

technical field [0001] The invention belongs to the technical field of composite biology, in particular to a slow-release nutritional VC lutein peptide chewable tablet and a preparation method thereof. Background technique [0002] With the continuous rapid development of my country's economy, the continuous improvement of living standards, the rapid development of my country's Internet, and the level of intelligence in mobile phones, mobile phones have become a part of our lives. Children, teenagers and other groups rely on mobile phones and electronic products, which also leads to widespread vision. The downward trend and phenomenon, the damage of screen light to the retina is slow and irreversible, which is a huge harm to the health of teenagers in our country, and it is urgent to protect the eyes of teenagers. [0003] According to a research report released by the World Health Organization in 2019, there are as many as 600 million people with myopia in China, almost half...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/00A23C9/152A23C9/156A23C9/158A23C9/18
CPCA23C9/1526A23C9/152A23C9/156A23C9/158A23C9/1522A23C9/18
Inventor 崔立万鹏
Owner SHANGHAI JIAO TONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products